Recce Pharmaceuticals Ltd
ASX:RCE

Watchlist Manager
Recce Pharmaceuticals Ltd Logo
Recce Pharmaceuticals Ltd
ASX:RCE
Watchlist
Price: 0.455 AUD -5.21% Market Closed
Market Cap: 105.5m AUD
Have any thoughts about
Recce Pharmaceuticals Ltd?
Write Note

Intrinsic Value

RCE's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one RCE stock under the Base Case scenario is 0.074 AUD. Compared to the current market price of 0.455 AUD, Recce Pharmaceuticals Ltd is Overvalued by 84%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

RCE Intrinsic Value
0.074 AUD
Overvaluation 84%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Recce Pharmaceuticals Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for RCE cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about RCE?
Bearish
Neutral
Bullish

Fundamental Analysis

0.455 AUD
-5.21%
-5.21%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Recce Pharmaceuticals Ltd
AU
Pharmaceuticals
Market Cap
105.5m AUD
IPO
Jan 15, 2016
Employees
-
Australia
Market Cap
105.5m AUD
Industry
Pharmaceuticals
IPO
Jan 15, 2016
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Recce Pharmaceuticals Ltd

Provide an overview of the primary business activities
of Recce Pharmaceuticals Ltd.

What unique competitive advantages
does Recce Pharmaceuticals Ltd hold over its rivals?

What risks and challenges
does Recce Pharmaceuticals Ltd face in the near future?

Has there been any significant insider trading activity
in Recce Pharmaceuticals Ltd recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Recce Pharmaceuticals Ltd.

Provide P/S
for Recce Pharmaceuticals Ltd.

Provide P/E
for Recce Pharmaceuticals Ltd.

Provide P/OCF
for Recce Pharmaceuticals Ltd.

Provide P/FCFE
for Recce Pharmaceuticals Ltd.

Provide P/B
for Recce Pharmaceuticals Ltd.

Provide EV/S
for Recce Pharmaceuticals Ltd.

Provide EV/GP
for Recce Pharmaceuticals Ltd.

Provide EV/EBITDA
for Recce Pharmaceuticals Ltd.

Provide EV/EBIT
for Recce Pharmaceuticals Ltd.

Provide EV/OCF
for Recce Pharmaceuticals Ltd.

Provide EV/FCFF
for Recce Pharmaceuticals Ltd.

Provide EV/IC
for Recce Pharmaceuticals Ltd.

What are the Revenue projections
for Recce Pharmaceuticals Ltd?

How accurate were the past Revenue estimates
for Recce Pharmaceuticals Ltd?

What are the Net Income projections
for Recce Pharmaceuticals Ltd?

How accurate were the past Net Income estimates
for Recce Pharmaceuticals Ltd?

What are the EPS projections
for Recce Pharmaceuticals Ltd?

How accurate were the past EPS estimates
for Recce Pharmaceuticals Ltd?

What are the EBIT projections
for Recce Pharmaceuticals Ltd?

How accurate were the past EBIT estimates
for Recce Pharmaceuticals Ltd?

Compare the revenue forecasts
for Recce Pharmaceuticals Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Recce Pharmaceuticals Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Recce Pharmaceuticals Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Recce Pharmaceuticals Ltd compared to its peers.

Compare the P/E ratios
of Recce Pharmaceuticals Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Recce Pharmaceuticals Ltd with its peers.

Analyze the financial leverage
of Recce Pharmaceuticals Ltd compared to its main competitors.

Show all profitability ratios
for Recce Pharmaceuticals Ltd.

Provide ROE
for Recce Pharmaceuticals Ltd.

Provide ROA
for Recce Pharmaceuticals Ltd.

Provide ROIC
for Recce Pharmaceuticals Ltd.

Provide ROCE
for Recce Pharmaceuticals Ltd.

Provide Gross Margin
for Recce Pharmaceuticals Ltd.

Provide Operating Margin
for Recce Pharmaceuticals Ltd.

Provide Net Margin
for Recce Pharmaceuticals Ltd.

Provide FCF Margin
for Recce Pharmaceuticals Ltd.

Show all solvency ratios
for Recce Pharmaceuticals Ltd.

Provide D/E Ratio
for Recce Pharmaceuticals Ltd.

Provide D/A Ratio
for Recce Pharmaceuticals Ltd.

Provide Interest Coverage Ratio
for Recce Pharmaceuticals Ltd.

Provide Altman Z-Score Ratio
for Recce Pharmaceuticals Ltd.

Provide Quick Ratio
for Recce Pharmaceuticals Ltd.

Provide Current Ratio
for Recce Pharmaceuticals Ltd.

Provide Cash Ratio
for Recce Pharmaceuticals Ltd.

What is the historical Revenue growth
over the last 5 years for Recce Pharmaceuticals Ltd?

What is the historical Net Income growth
over the last 5 years for Recce Pharmaceuticals Ltd?

What is the current Free Cash Flow
of Recce Pharmaceuticals Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Recce Pharmaceuticals Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Recce Pharmaceuticals Ltd

Current Assets 5.1m
Cash & Short-Term Investments 4.5m
Receivables 450.5k
Other Current Assets 221.7k
Non-Current Assets 1.2m
PP&E 1.2m
Current Liabilities 15.1m
Accounts Payable 4.6m
Accrued Liabilities 118.6k
Other Current Liabilities 10.4m
Non-Current Liabilities 823.7k
Long-Term Debt 587.1k
Other Non-Current Liabilities 236.5k
Efficiency

Earnings Waterfall
Recce Pharmaceuticals Ltd

Revenue
5.2m AUD
Operating Expenses
-22.1m AUD
Operating Income
-16.8m AUD
Other Expenses
-846.9k AUD
Net Income
-17.7m AUD

Free Cash Flow Analysis
Recce Pharmaceuticals Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

RCE Profitability Score
Profitability Due Diligence

Recce Pharmaceuticals Ltd's profitability score is 39/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Exceptional ROE
Exceptional ROIC
ROE is Increasing
39/100
Profitability
Score

Recce Pharmaceuticals Ltd's profitability score is 39/100. The higher the profitability score, the more profitable the company is.

RCE Solvency Score
Solvency Due Diligence

Recce Pharmaceuticals Ltd's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Long-Term Solvency
Short-Term Solvency
45/100
Solvency
Score

Recce Pharmaceuticals Ltd's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

RCE Price Targets Summary
Recce Pharmaceuticals Ltd

There are no price targets for RCE.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for RCE?

Click here to dive deeper.

Dividends

Recce Pharmaceuticals Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for RCE is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

RCE Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

See Also

Discover More
What is the Intrinsic Value of one RCE stock?

The intrinsic value of one RCE stock under the Base Case scenario is 0.074 AUD.

Is RCE stock undervalued or overvalued?

Compared to the current market price of 0.455 AUD, Recce Pharmaceuticals Ltd is Overvalued by 84%.

Back to Top